starting & switching dmts | ean 2020 summary by multiple sclerosis academy
Published 4 years ago • 488 plays • Length 13:56Download video MP4
Download video MP3
Similar videos
-
33:40
progressive ms & starting and switching dmts – part 2 | ean 2020 summary by ms academy
-
14:24
dmt safety issues | ean 2020 summary by multiple sclerosis academy
-
12:48
progressive ms | ean 2020 summary by multiple sclerosis academy
-
5:59
ean 2020: introduction and reflections on a virtual congress | multiple sclerosis academy
-
3:39
ms: the basics - the different types of multiple sclerosis
-
14:49
“choosing the right disease-modifying therapy,” geeta ganesh, m.d.
-
1:54
2-minute neuroscience: multiple sclerosis
-
![when to upgrade an ms disease modifying therapy [all 5 reasons]](https://i.ytimg.com/vi/3EdsFDI-8R0/mqdefault.jpg)
5:23
when to upgrade an ms disease modifying therapy [all 5 reasons]
-
0:16
treatment sequencing in multiple sclerosis: the benefits of disease-modifying therapies
-
1:29
ask dhr: what is multiple sclerosis?
-
1:43
ms: the basics - what is multiple sclerosis?
-
5:03
bianca weinstock-guttman, ean 2020 – chords study in rrms with suboptimal prior response to dmts
-
21:47
ms variance – dr gordon mazibrada: implementing the nhse stopping criteria for dmts
-
3:02
prof giovannoni and dr paling about the ms debate at the icc birmingham 2018
-
3:48
the effect of disease modifying treatment in multiple sclerosis patients
-
3:57
xavier montalban, ean 2020 – long-term phase ii outcomes of first oral btk inhibitor in ms
-
2:36
david garmon-jones about the nhs england algorithm for ms treatment by disease-modifying drugs
-
4:33
ms: the basics - what causes multiple sclerosis?
-
58:42
debate on the nhs england algorithm for ms treatment by disease-modifying drugs